Is This Blue Chip Stock a Buy for Value Investors?
Certain demographics are incredibly important to a number of economic sectors, and that includes healthcare. With the global median age projected to rise from just under 31 years in 2020 to just over 36 years by 2050, demand for healthcare services is bound to grow as well. Leading health insurer and pharmacy chain CVS Health (NYSE: CVS) is poised to cash in on this favorable demographic in the future.
That suggests growth in CVS Health's future. But is the stock a buy for value-oriented investors? Let's delve into the health of CVS Health's fundamentals and its valuation and see if an answer presents itself.
CVS Health is an incredibly well-established business. For one, 85% of Americans live within 10 miles of a CVS Pharmacy location. Second, the company serves more than 100 million customers each year through its pharmacy benefits manager brand, Caremark, and its health insurance brand, Aetna.
Source Fool.com
